The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


DICP, The Annals of Pharmacotherapy: Vol. 23, No. 1, pp. 59-62.
© 1989 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baptista, R.
Right arrow Articles by Perri-LaFrancesca, J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baptista, R.
Right arrow Articles by Perri-LaFrancesca, J


Research Articles

Home intermittent amrinone infusions in terminal congestive heart failure

RJ Baptista, FP Mitrano, and J Perri-LaFrancesca

The prevalence of congestive heart failure (CHF) and its progressive degenerative course continue to generate pressure for alternative, more effective means of treatment. A confluence of factors, including the number of Americans with CHF, the spiraling costs of hospital care, and increasing interest in cost-effective home care, contribute to the current efforts to develop an effective, nontoxic therapy that effectively increases myocardial contractility and output and can be administered within the confines of the home. Given that preliminary clinical trials in the hospital setting with amrinone have produced positive results, the transition of this therapy to the home, when administered intermittently via central venous catheter and infusion pump, was undertaken. In order to prolong and increase quality of life in terminal CHF patients, intermittent amrinone infusions were provided at home to four patients as part of our pilot program. All four patients met the criteria for New York Heart Association (NYHA) functional class IV heart failure, and none had responded to conventional therapy suitable for outpatient maintenance. The patients also shared strong family support and an intense desire to improve the quality of remaining life. All four patients and designated family members were trained in the specifics of aseptic technique, medication dose preparation, central venous catheter care, and operation of an infusion pump. An ambulatory pump was used in three of the four patients. Subsequent to the initiation of intermittent home amrinone infusions, all four patients had greater tolerance to limited exercise and/or ambulation secondary to increased cardiac output and diuresis. Patients survived 8, 10, 47, and 56 weeks.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
M. A. Bennett and R. D. Allen
High-Technology Home Pharmacotherapy, II: An Overview of the Newest Home Therapies
Journal of Pharmacy Practice, January 1, 1990; 3(1): 40 - 47.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1989 by Harvey Whitney Books Company.